Clinical Trials in Houston

Showing 2201-2220 of 8,625 trials

Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma

NCT00592592

The main purpose of this study is to see if using proton beam radiation therapy instead of photon beam radiation therapy can reduce side effects from radiation treatment for rhabdomyosarcoma. Photon beam radiation is the standard type of radiation for treating most rhabdomyosarcoma and many other types of cancer. Photon beam radiation enters the body and passes through healthy tissue, encounters the tumor, then leaves the body through healthy tissue. A beam of proton radiation enters the body and passes through healthy tissue, encounters tumor, but then stops. This means that less healthy tissue is affected by proton beam radiation than by photon beam radiation.

Rhabdomyosarcoma

Massachusetts General Hospital115 participantsStarted Oct 2004

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Houston, Texas, United States

COMPLETEDPhase 2/3< 1 mile

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

NCT05133336

Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis

Zydus Therapeutics Inc.196 participantsStarted Apr 2022

Birmingham, Alabama, United States • Tucson, Arizona, United States • Los Angeles, California, United States +54 more locations

Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

Find Trials by Condition in Houston

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

Shared-Decision Making for Hydroxyurea

Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

DETECT-RPC Universal EM Screening

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

Pilot Study of Virtual Reality Therapy for Students With Anxiety

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

EluPro Antibiotic-Eluting BioEnvelope Registry

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia